Medical Education Division
Our Products
On-Line Store

Google
 
Web www.brooksidepress.org

Operational Medicine 2001*
Measles (Rubeola, Morbilli, 9-Day Measles)

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Phone Consultation  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

 
 

Measles is a very contagious viral illness with fever, cough, nasal congestion, characteristic rash, and irritation of the mucous membranes (Koplik's spots).

There is a 7-10 day incubation period following exposure. The initial symptoms are flu-like, with nasal itching, fever, dry hacky cough and inflammation of the conjunctiva. 

  • 2-4 days later, Koplik's spots appear. These look like white grains of sand, surrounded by raised, red areas on the inside of the mouth or lips.
  • 3-5 days after initial symptoms, the rash appears. These are raised, red skin lesions, starting on the sides of the neck and spreading downward over the next 24-48 hours to the trunk and ultimately to the extremities. This head-downward spread is characteristic of the disease.

At this stage, the host appears to be quite ill, with high fever (up to 104), mild itching, coughing, and sensitivity to light. After 3-5 days of discomfort, the fever goes away, the rash rapidly disappears, and recovery is prompt.

In otherwise healthy individuals, there is a very low mortality rate, and most complications are due to bacterial superinfections (particularly streptococcal). This may include pneumonia, otitis medica or pharyngitis. During the illness, the immune system is pre-occupied and reactivation of latent diseases (eg TB) can occur.

In immunocompromised individuals, the disease may be more lengthy, the risk of superinfection is increased, and the usually rare complications of myocarditis, pericarditis, glomerulonephritis, coma and encephalitis are increased. Also at risk are children less than 5 years old, and those with Vitamin A deficiency.

It is spread by aerosol contamination from the nose or mouth in tiny droplets. Infected individuals are contagious starting 4 days before the rash appears and continuing until the rash disappears.A previous infection normally confers life-time immunity. Nearly as effective is active immunization. Newborn infants of mothers who are immune receive temporary, passive immunity from the placenta, lasting the better part of the first year of life.

Measles is sometimes confused clinically with:

Rubella (German Measles) German measles has a much milder clinical course with little or no fever, enlarged, tender lymph nodes behind the ears and the back of the neck. It lasts a shorter period of time.
Drug reaction While the rash of a drug hypersensitivity reaction can resemble that of measles, with drug reactions the rash usually appears everywhere at once, rather than progressing from the head downward. Also, drug rashes often involve the palms and soles, while measles usually does not. Further, there is usually no prodromal symptoms of itchy nose, hacking cough, and very high fever.
Scarlet fever While both can begin with fever and pharyngitis, the Scarlet fever rash is quite different.
Roseola This condition ordinarily occurs in children under the age of 3. The rash can be similar to that of measles, but the rash of Roseola usually appears just as the fever is going away. Koplik's spots are seen in measles, but not in Roseola.

Immunization is with a weakened form of the virus which leads to a clinically mild (or absent) illness that is not contagious. In fewer than 5% of individuals, a temperature of 101 degrees and rash develop 5-12 days after immunization. Immunization should not be done to pregnant women, immunocompromized individuals, or those with widespread malignancy. Those already exposed may be immunized, but this should be within 2 days of exposure to be effective.

Treatment is generally supportive, but Vitamin A, 400,000 IU orally seems to reduce the morbidity and mortality of the illness, particularly in malnourished or undernourished populations.


Approved for public release; Distribution is unlimited.

The listing of any non-Federal product in this CD is not an endorsement of the product itself, but simply an acknowledgement of the source. 

Operational Medicine 2001

Health Care in Military Settings

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

Contact Us  ·  ·  Other Brookside Products